On February 4, 2016, an order regarding the application for authority to retain professionals was filed in the bankruptcy case of KaloBios Pharmaceuticals, Inc. and its affiliates.
The filing was assigned docket number 146 and is described on the court’s official docket as follows:
Order Granting Application of the Debtor for Entry of an Order Pursuant to Bankruptcy Code Sections 327(a), 328, 330, and 1107 Authorizing Employment and Retention of Hogan Lovells US LLP as Bankruptcy Counsel for the Debtor in Possession Nunc Pro Tunc to the Petition Date and Statement Required by Bankruptcy Code Section 329, and for Authorization to Apply Retainer to Payment of Fees and Expenses Incurred in Connection with Services Rendered by Hogan Lovells US LLP Pre-Petition (Related Doc # ) Order Signed on 2/4/2016. (TC)
KaloBios Pharmaceuticals, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 29, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 15-12628. The bankruptcy case is currently assigned to United States Bankruptcy Judge Laurie Selber Silverstein. The law firm of Morris, Nichols, Arsht & Tunnell LLP is acting as lead bankruptcy counsel to KaloBios Pharmaceuticals, Inc. in the bankruptcy case.